Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Signify Health Is Surging on Wednesday

By Cory Renauer – Nov 10, 2021 at 2:17PM

Key Points

  • Helping hospital systems improve their profit margins with in-home evaluations of recently discharged patients is a booming business.
  • Signify reported strong growth on the top and bottom lines during the third quarter and raised guidance ranges for the full year.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors were more than impressed with the company's third-quarter earnings results.

What happened

Shares of Signify Health (SGFY -0.21%), a healthcare platform company, are on the move in after the company reported highly positive third-quarter earnings results. Investors impressed with growth on the top and bottom lines pushed the stock 16% higher as of 12:40 p.m. EST on Wednesday.

So what 

Total revenue soared 29% year over year to $199.2 million during the third quarter, driven largely by increasing demand for in-home evaluations. Those evaluations performed during the quarter soared 25% year over year to 488,000.

Medical professional assists person who uses walker.

Image source: Getty Images.

On the bottom line, net income rose to a positive $29.3 million from a loss of $13.3 million in the previous-year period. The company even raised its outlook for total revenue from between $745 million and $765 million to somewhere between $755 million and $770 million. 

Now what

Signify Health also raised estimates for earnings before interest, taxes, depreciation, and amortization (EBITDA) from between $155 million and $165 million to between $160 million and $170 million. The company also expects to facilitate more than 1.8 million in-home evaluations this year.

Medicare Advantage and other government-run plans are increasingly likely to pay hospitals a set price for specific episodes of care, such as a knee replacement or a heart attack. This means hospitals have a lot more financial incentive to monitor patients after they're discharged to ensure they don't need to return. Today's stellar earnings report probably won't be the last one we see from this company.

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.